These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15372850)

  • 21. Safeguarding future antimicrobial options: strategies to minimize resistance.
    Leclercq R
    Clin Microbiol Infect; 2001; 7 Suppl 3():18-23. PubMed ID: 11523557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barriers to the effective management of respiratory tract infections in the community.
    Saginur R
    Infection; 2001 Dec; 29 Suppl 2():3-10. PubMed ID: 11785853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.
    Čipčić Paljetak H; Verbanac D; Padovan J; Dominis-Kramarić M; Kelnerić Ž; Perić M; Banjanac M; Ergović G; Simon N; Broskey J; Holmes DJ; Eraković Haber V
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5337-48. PubMed ID: 27353268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia.
    Cilloniz C; Albert RK; Liapikou A; Gabarrus A; Rangel E; Bello S; Marco F; Mensa J; Torres A
    Am J Respir Crit Care Med; 2015 Jun; 191(11):1265-72. PubMed ID: 25807239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of pneumococcal resistance and factors influencing outcomes.
    Bishai WR
    Treat Respir Med; 2005; 4 Suppl 1():19-23. PubMed ID: 15846153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteremic pneumococcal pneumonia associated with macrolide failure.
    Dylewski J; Davidson R
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):39-42. PubMed ID: 16411124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America.
    Hoban DJ
    J Chemother; 2002 Jul; 14 Suppl 3():25-30. PubMed ID: 12418558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
    Zhanel GG; Hartel E; Adam H; Zelenitsky S; Zhanel MA; Golden A; Schweizer F; Gorityala B; Lagacé-Wiens PR; Walkty AJ; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2016 Dec; 76(18):1737-1757. PubMed ID: 27909995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance.
    Metlay JP; Singer DE
    Clin Microbiol Infect; 2002; 8 Suppl 2():1-11. PubMed ID: 12427205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hidden impact of antibacterial resistance in respiratory tract infection. Clinical failures: the tip of the iceberg?
    Garau J
    Respir Med; 2001 Jun; 95 Suppl A():S5-11; discussion S26-7. PubMed ID: 11419672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program.
    Gordon KA; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2003 Aug; 46(4):285-9. PubMed ID: 12944021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First detection and characterization of macrolide-resistant Mycoplasma pneumoniae strains in Cuba.
    Rodriguez N; Mondeja B; Sardiñas R; Vega D; Dumke R
    Int J Infect Dis; 2019 Mar; 80():115-117. PubMed ID: 30634044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and public health implications of macrolide-resistant Streptococcus pneumoniae.
    Moellering RC; Craig W; Edmond M; Farrell DJ; Ferraro MJ; File TM; Klein J; Lonks J; Metlay JP; Sahm D; Talbot GH;
    J Chemother; 2002 Jul; 14 Suppl 3():42-56. PubMed ID: 12418560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and economic implications of antimicrobial resistance for the management of community-acquired respiratory tract infections.
    Nicolau D
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():61-70. PubMed ID: 12239229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the relevance of antimicrobial resistance on the outcome of community-acquired pneumonia caused by Streptococcus pneumoniae? (should macrolide monotherapy be used for mild pneumonia?).
    Low DE
    Infect Dis Clin North Am; 2013 Mar; 27(1):87-97. PubMed ID: 23398867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From macrolides to ketolides: What is available for the treatment of outpatient respiratory tract infections?
    Carter PL
    Postgrad Med; 2002 Sep; 112(3 Suppl):18-25. PubMed ID: 19667591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials.
    Fogarty CM; Greenberg RN; Dunbar L; Player R; Marrie TJ; Kojak CM; Morgan N; Williams RR
    Clin Ther; 2001 Mar; 23(3):425-39. PubMed ID: 11318077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01.
    Doern GV; Brown SD
    J Infect; 2004 Jan; 48(1):56-65. PubMed ID: 14667792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.